.png)
Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma cells and confers susceptibility to temozolomide
- Authors: Megías, J., Martínez, A., San-Miguel, T., Gil, R., Muñoz, L., Albert, D., Carratalá, A., Gozalbo, D., López, C., Gil, M.L. and Cerdá, M. (2020).
- Publication types: Article
- Publication Title (name of the book or magazine): Investigational New Drugs.
38(2), 299-310. Doi: 10.1007/s10637-019-00788-2. (2020)
Category: “Pharmacology and Pharmacy”, Rank: 80/271 (Q2), IF: 3.525 (2019)
